Corporate Overview for Investors slide image

Corporate Overview for Investors

* ** Excellent Financial Execution Revenue (M) $4,204 $3,685 $3,361 $3,121 $2,725 Non-GAAP EPS* $5,060-$5,090 (20% -21% y/y) $6.84 $5.55 $4.56 $3.91 $3.42 $8.80-$8.85 (-29% y/y) FY17 FY18 FY19 FY20 FY21 FY22E** FY17 FY18 FY19 FY20 FY21 FY22E** Recurring revenue model with $7.1B non- cancellable backlog provides stability throughout the business cycle A GAAP to non-GAAP reconciliation of FY17 to FY22E earnings per share is included at the end of this presentation FY22E reflects guidance provided as of August 17, 2022 Strong financial execution while investing for long-term growth synopsys® Synopsys Confidential Information 2022 Synopsys, Inc. 44
View entire presentation